Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfreundschuh

Showing results (181-190 of 260) with videos related to

Pageof 26
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphomaB Glass, M Ziepert, M Reiser, et al.
Leukemia|August 30, 2008
Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)W Klapper, H Stoecklein, S Zeynalova, et al.
Blut|June 1, 1988
Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study GroupM Loeffler, M Pfreundschuh, D Hasenclever, et al.
Leukemia & Lymphoma|August 1, 1992
The clinical significance of cytokines and soluble forms of membrane-derived activation antigens in the serum of patients with Hodgkin's diseaseA Gause, W Jung, S Keymis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 1995
Human neoplasms elicit multiple specific immune responses in the autologous hostU Sahin, O Türeci, H Schmitt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: results from single-cell cDNA analysisL Trümper, H Daus, H Merz, et al.
Onkologie|February 1, 1988
[Therapy of Hodgkin's lymphomas. Results of the German Hodgkin's Disease Study Group]M Pfreundschuh, M Löffler, U Rühl, et al.
Digestion|January 30, 2010
Genotypic interaction and gender specificity of common genetic variants in the p53/mdm2 network in Crohn's diseaseV Zimmer, T Widmann, M Müller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2009
High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)M Nickelsen, M Ziepert, S Zeynalova, et al.
British Journal of Cancer|April 1, 1992
Monoclonal antibody FW6 generated against a mucin-carbohydrate of human amniotic fluid recognises a colonic tumour-associated epitopeM Schwonzen, R Schmits, S E Baldus, et al.
Pageof 26

Showing results (181-190 of 260) with videos related to

Sort By:
Pageof 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphomaB Glass, M Ziepert, M Reiser, et al.
Leukemia|August 30, 2008
Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)W Klapper, H Stoecklein, S Zeynalova, et al.
Blut|June 1, 1988
Prognostic risk factors in advanced Hodgkin's lymphoma. Report of the German Hodgkin Study GroupM Loeffler, M Pfreundschuh, D Hasenclever, et al.
Leukemia & Lymphoma|August 1, 1992
The clinical significance of cytokines and soluble forms of membrane-derived activation antigens in the serum of patients with Hodgkin's diseaseA Gause, W Jung, S Keymis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 1995
Human neoplasms elicit multiple specific immune responses in the autologous hostU Sahin, O Türeci, H Schmitt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
NPM/ALK fusion mRNA expression in Hodgkin and Reed-Sternberg cells is rare but does occur: results from single-cell cDNA analysisL Trümper, H Daus, H Merz, et al.
Onkologie|February 1, 1988
[Therapy of Hodgkin's lymphomas. Results of the German Hodgkin's Disease Study Group]M Pfreundschuh, M Löffler, U Rühl, et al.
Digestion|January 30, 2010
Genotypic interaction and gender specificity of common genetic variants in the p53/mdm2 network in Crohn's diseaseV Zimmer, T Widmann, M Müller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2009
High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)M Nickelsen, M Ziepert, S Zeynalova, et al.
British Journal of Cancer|April 1, 1992
Monoclonal antibody FW6 generated against a mucin-carbohydrate of human amniotic fluid recognises a colonic tumour-associated epitopeM Schwonzen, R Schmits, S E Baldus, et al.
Pageof 26